How many insider trades does FilingIQ track for FENC?

FilingIQ tracks 488 Form 4 insider transactions for FENC (FENNEC PHARMACEUTICALS INC.), covering filings from Dec 14, 2017 onwards. 24 of those are dated within the last 90 days.

Are FENC insiders net buyers or net sellers?

Across the full Form 4 history for FENC, 185 transactions (38%) were open-market purchases and 123 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does FENC insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is FENC in?

FENNEC PHARMACEUTICALS INC. (FENC) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $307.04M.

FENC insider trading

NasdaqCM Healthcare

FENNEC PHARMACEUTICALS INC.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

488

Last 90 days

Buys / sells

38% / 25%

Market cap

$307.04M

About FENNEC PHARMACEUTICALS INC.

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Company website: fennecpharma.com

FENC insider activity at a glance

FilingIQ tracks 488 insider transactions for FENC in filings since Dec 14, 2017. The most recent transaction is dated Sep 30, 2026.

Across the full history, 185 open-market purchases and 123 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on FENC insider trades is 45.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live FENC trades on FilingIQ Raw filings on SEC EDGAR

Latest FENC Form 4 filings

Cioffi Christiana Marie Chief Strategy Officer

A Oct 1, 2026

Sayad Pierre Sargis Chief Medical Officer

A Oct 1, 2026

Evans Terry L Chief Commercial Officer

A Oct 1, 2026

Hackman Jeffrey S. Chief Executive Officer

A Oct 1, 2026

Andrade Robert CHIEF FINANCIAL OFFICER

Cioffi Christiana Marie Chief Strategy Officer

A Aug 31, 2026

Sayad Pierre Sargis Chief Medical Officer

SA Aug 31, 2026

Evans Terry L Chief Commercial Officer

A Aug 31, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

Frequently asked

How many insider trades does FilingIQ track for FENC?: FilingIQ tracks 488 Form 4 insider transactions for FENC (FENNEC PHARMACEUTICALS INC.), covering filings from Dec 14, 2017 onwards. 24 of those are dated within the last 90 days.
Are FENC insiders net buyers or net sellers?: Across the full Form 4 history for FENC, 185 transactions (38%) were open-market purchases and 123 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does FENC insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is FENC in?: FENNEC PHARMACEUTICALS INC. (FENC) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $307.04M.

Methodology & sources

Every FENC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.